Skip to main content
Figure 4 | Journal of Translational Medicine

Figure 4

From: Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

Figure 4

Plasma thrombomodulin (TM) levels measured in septic placebo controls and ascorbic acid infused patients. Plasma TM levels measured in the ascorbic acid infused patients exhibited no rise throughout the 4 days of study. Patients in the placebo group showed a trend towards increased plasma TM levels beginning at 36 hours, though it did not achieve statistical significance. Placebo (О), Lo-AscA (▼), Hi-AscA (▲).

Back to article page